Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Debt to Assets Ratio: 41.86%

popular:market cap|pe ratio|revenue|price history|total return

Is the debt to assets ratio high or low?

The debt to assets ratio of 41.86% is 11% above its 5-year average of 37.77%, near the high end of its 5-year range (33.46%–43.31%).

As of Friday, June 26, 2026. 1.87% above its 12-month average of 41.10%.

Debt/Equity|Total Debt|Total Assets|Interest Coverage|All Metrics
Debt to Assets

DGX Debt to Assets Ratio

41.86%

Reported quarterly debt to assets ratio; no daily interpolation.

+15.86% 5Y
DGX Debt to Assets Ratio

DGX Average Debt to Assets Ratio Chart

DGX Debt to Assets Ratio

DGX Current vs Average Debt to Assets Ratio Chart

DGX Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

41.86%

DEBT TO ASSETS RATIO AVG TTM

41.10%

DEBT TO ASSETS RATIO AVG 3Y

39.57%

DEBT TO ASSETS RATIO AVG 5Y

37.77%

DEBT TO ASSETS RATIO AVG 10Y

37.00%

DEBT TO ASSETS RATIO AVG 15Y

38.06%

DEBT TO ASSETS RATIO AVG 20Y

37.83%

CURRENT VS TTM AVG

+1.87%

CURRENT VS 3Y AVG

+5.79%

CURRENT VS 5Y AVG

+10.84%

CURRENT VS 10Y AVG

+13.15%

CURRENT VS 15Y AVG

+10.00%

CURRENT VS 20Y AVG

+10.67%

DGX Competitors' Debt to Assets Ratio

NAMEMARKET CAPDEBT TO ASSETS RATIOTTM3Y5Y
Quest Diagnostics Incorporated (DGX)$22.83B41.86%41.10%39.57%37.77%
BioNTech SE (BNTX)vs ›$22.76B0.01%N/AN/AN/A
United Therapeutics Corporation (UTHR)vs ›$23.07B0.00%N/AN/AN/A
Moderna, Inc. (MRNA)vs ›$23.71B0.16%N/AN/AN/A
Labcorp Holdings Inc. (LH)vs ›$21.83B0.39%N/AN/AN/A
Incyte Corporation (INCY)vs ›$21.48B0.01%N/AN/AN/A
Waters Corporation (WAT)vs ›$24.57B0.29%N/AN/AN/A
Mettler-Toledo International Inc. (MTD)vs ›$25.13B0.63%N/AN/AN/A
STERIS plc (STE)vs ›$20.52B0.19%N/AN/AN/A
Veeva Systems Inc. (VEEV)vs ›$25.68B0.01%N/AN/AN/A

Leverage Ratios Comparison

Debt/Assets

41.9%

Debt/Equity

0.96

Current Ratio

1.04

Interest Coverage

5.8x

Formula: Debt/Assets = Total Debt / Total Assets × 100

Debt/Assets vs Debt/Equity:

  • Debt/Assets: Shows % of assets funded by creditors (bounded 0-100%)
  • Debt/Equity: Shows debt relative to shareholder investment (can exceed 100%)
  • Both measure leverage but from different perspectives

Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.

Debt to Assets Ratio Formula & Definition

Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Quest Diagnostics Incorporated (DGX)?
The debt to assets ratio for DGX stock is 41.86%.
Is Quest Diagnostics Incorporated's debt to assets ratio high or low?
The debt to assets ratio of 41.86% is 11% above its 5-year average of 37.77%, near the high end of its 5-year range (33.46%–43.31%).
What is the TTM average debt to assets ratio for Quest Diagnostics Incorporated (DGX)?
The TTM average debt to assets ratio for DGX stock is 41.10%.
What is the 3Y average debt to assets ratio for Quest Diagnostics Incorporated (DGX)?
The 3Y average debt to assets ratio for DGX stock is 39.57%.
What is the 5Y average debt to assets ratio for Quest Diagnostics Incorporated (DGX)?
The 5Y average debt to assets ratio for DGX stock is 37.77%.
What is the 10Y average debt to assets ratio for Quest Diagnostics Incorporated (DGX)?
The 10Y average debt to assets ratio for DGX stock is 37.00%.
What is the 15Y average debt to assets ratio for Quest Diagnostics Incorporated (DGX)?
The 15Y average debt to assets ratio for DGX stock is 38.06%.
What is the 20Y average debt to assets ratio for Quest Diagnostics Incorporated (DGX)?
The 20Y average debt to assets ratio for DGX stock is 37.83%.

DGX Debt to Assets Ratio History

DATEDEBT TO ASSETS RATIO
2026-03-3141.86%
2025-12-3142.64%
2025-09-3039.40%
2025-06-3039.98%
2025-03-3141.59%
2024-12-3142.87%
2024-09-3043.31%
2024-06-3036.65%
2024-03-3138.35%
2023-12-3138.29%
2023-09-3036.43%
2023-06-3036.94%
2023-03-3136.13%
2022-12-3136.01%
2022-09-3035.09%
2022-06-3034.83%
2022-03-3134.69%
2021-12-3134.21%
2021-09-3034.26%
2021-06-3036.13%
2021-03-3133.46%
2020-12-3133.19%
2020-09-3036.41%
2020-06-3039.55%
2020-03-3138.09%
2019-12-3141.49%
2019-09-3037.82%
2019-06-3038.56%
2019-03-3140.02%
2018-12-3135.38%
2018-09-3033.66%
2018-06-3034.55%
2018-03-3136.08%
2017-12-3136.03%
2017-09-3036.06%
2017-06-3036.74%
2017-03-3136.91%
2016-12-3136.97%
2016-09-3037.57%
2016-06-3038.01%
2016-03-3138.61%
2015-12-3136.65%
2015-09-3037.04%
2015-06-3038.44%
2015-03-3144.58%
2014-12-3137.89%
2014-09-3039.42%
2014-06-3040.57%
2014-03-3141.33%
2013-12-3137.24%
2013-09-3037.71%
2013-06-3038.69%
2013-03-3136.55%
2012-12-3136.23%
2012-09-3037.88%
2012-06-3040.70%
2012-03-3141.47%
2011-12-3143.22%
2011-09-3045.07%
2011-06-3045.89%
2011-03-3145.99%
2010-12-3135.06%
2010-09-3037.44%
2010-06-3037.08%
2010-03-3136.58%
2009-12-3136.28%
2009-09-3035.64%
2009-06-3037.54%
2009-03-3136.93%
2008-12-3136.69%
2008-09-3036.51%
2008-06-3038.05%
2008-03-3139.64%
2007-12-3141.34%
2007-09-3043.86%
2007-06-3046.06%
2007-03-3132.41%
2006-12-3127.48%
2006-09-3027.27%
2006-06-3028.13%
2006-03-3128.20%
2005-12-3130.01%
2005-09-3018.84%
2005-06-3018.95%
2005-03-3119.67%
2004-12-3126.14%
2004-09-3025.07%
2004-06-3025.35%
2004-03-3125.17%
2003-12-3125.63%
2003-09-3026.32%
2003-06-3026.85%
2003-03-3129.26%
2002-12-3124.74%
2002-09-3030.24%
2002-06-3032.52%

Related Metrics

Debt/EquityTotal DebtTotal AssetsInterest CoverageAll Metrics

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
www.questdiagnostics.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
View full financials